ABL

ABL, Inc. is a global contract development and manufacturing organization empowering our clients to conquer the world’s most challenging diseases. ABL’s GMP facilities in the U.S. and Europe have established a successful track record manufacturing GMP viruses used for gene therapy, oncolytic vector and vaccine products. Our virus production services include process and assay development, GMP manufacture of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC bioanalytical testing.